Lori Wampler, SLP in Hood River, OR - Speech-Language Pathologist

Lori Wampler, SLP is a Speech-language Pathologist based in Hood River, Oregon. Lori Wampler is licensed to practice in Oregon (license number 13322) and her current practice location is 117 E Eugene St, Hood River, Oregon. She can be reached at her office (for appointments etc.) via phone at (503) 267-2470.

NPI number for Lori Wampler is 1912690389 and her current mailing address is 117 E Eugene St, Hood River, Oregon. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1912690389.

Contact Information

	Lori Wampler, SLP
	117 E Eugene St, Hood River, OR 97031-2386
	(503) 267-2470
	Not Available

Healthcare Provider's Profile

Full Name	Lori Wampler
Gender	Female
Speciality	Speech-language Pathologist
Location	117 E Eugene St, Hood River, Oregon
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1912690389
Provider Enumeration Date: 05/31/2023
Last Update Date: 05/31/2023

Medical Identifiers

Medical identifiers for Lori Wampler such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1912690389	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	13322 (Oregon)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Lori Wampler is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Lori Wampler, SLP 117 E Eugene St, Hood River, OR 97031-2386 Ph: (503) 267-2470	Lori Wampler, SLP 117 E Eugene St, Hood River, OR 97031-2386 Ph: (503) 267-2470

News Archive

Practical guidance for cardiothoracic transplant programs in view of H1N1 flu pandemic

Each year 3-5 million people have severe cases and 250-500,000 die from complications of seasonal influenza world-wide. This year, the novel 2009 H1N1 (nH1N1) influenza, previously called swine flu, has reached pandemic status.

CID to provide update on Cre8 polymer-free DES program at TCT 2010

CID s.r.l., a European company leader in interventional medicine, will update interventional cardiologists on the status of their revolutionary drug eluting stent technology during The Drug Eluting Stent (DES) Summit at TCT 2010, Washington, DC on Wednesday, September 22, 2010. The lecture, entitled "Status of the CID Cre8 polymer-free DES program", will be delivered by Alexandre Abizaid, MD, PhD. Chief of Intervention at Instituto Dante Pazzanese, in Sao Paulo Brazil, and will be part of the session "The Next Generation DES, Polymer-Free".

study shows compounds from soy affect brain and reproductive development

Two hormone-like compounds linked to the consumption of soy-based foods can cause irreversible changes in the structure of the brain, resulting in early-onset puberty and symptoms of advanced menopause in research animals, according to a new study by researchers at North Carolina State University. The study is a breakthrough in determining how these compounds can cause reproductive health problems, as well as in providing a key building block for how to treat these problems.

New implantable sensor to continuously monitor tissue glucose

Bioengineers at the University of California, San Diego and GlySens Incorporated have developed an implantable glucose sensor and wireless telemetry system that continuously monitors tissue glucose and transmits the information to an external receiver. The paper, published in the July 28, 2010 issue of the journal Science Translational Medicine, describes the use of this glucose-sensing device as an implant in animals for over one year. After human clinical trials and FDA approval, the device may be useful to people with diabetes as an alternative to finger sticking and short-term, needle-like glucose sensors that have to be replaced every three to seven days.

Vitamin B1 deficiency key to vascular problems for diabetic patients

Researchers at Warwick Medical School, University of Warwick, have discovered that deficiency of thiamine - vitamin B1 - may be key to a range of vascular problems for people with diabetes.

Speech-Language Pathologist in Hood River, OR

Ms. Eliza Louise Heavenrich, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 805 State St Apt 2, Hood River, OR 97031 Phone: 503-298-1009
Megan Marie Burfield, M.S., CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 315 Oak St Ste 200, Hood River, OR 97031 Phone: 541-386-0009 Fax: 541-386-0029
Juliana Stevens Cuyler, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1015 Hutson Rd, Hood River, OR 97031 Phone: 541-806-9193
Rebecca Michelle Tunell, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 315 Oak St Ste 200, Hood River, OR 97031 Phone: 541-386-0009
Jenna Lynette Bartley, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1706 Avalon Dr Unit 23, Hood River, OR 97031 Phone: 541-645-0582
Nicole Kvist, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1700 12th St Ste C, Hood River, OR 97031 Phone: 541-716-1316
Kimberley Ann Ellis, MA/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1627 Woods Ct, Hood River, OR 97031 Phone: 541-387-1949

Lori Wampler, SLP - Speech-Language Pathologist in Hood River, OR